A rating of 81 puts Amgen, Inc. (AMGN) near the top of the Drug Manufacturers - General industry according to InvestorsObserver. Amgen, Inc.'s score of 81 means it scores higher than 81% of stocks in the industry. Amgen, Inc. also received an overall rating of 73, putting it above 73% of all stocks. Drug Manufacturers - General is ranked 2 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 73 would rank higher than 73 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Amgen, Inc. Stock Today?
Amgen, Inc. (AMGN) stock is trading at $227.79 as of 2:27 PM on Tuesday, Apr 14, a gain of $9.52, or 4.36% from the previous closing price of $218.27. The stock has traded between $220.25 and $228.00 so far today. Volume today is light. So far 1,753,112 shares have traded compared to average volume of 4,064,301 shares.
To see the top 5 stocks in Drug Manufacturers - General click here.
